MENU
+Compare
HRGN
Stock ticker: OTC
AS OF
Jun 24 closing price
Price
$1.60
Change
+$0.01 (+0.63%)
Capitalization
25.47M

HRGN Harvard Apparatus Regenerative Technology Inc. Forecast, Technical & Fundamental Analysis

Harvard Apparatus Regenerative Technology Inc is a clinical-stage biotechnology company developing regenerative-medicine treatments for disorders of the gastrointestinal system and the airway resulting from cancer, trauma, or birth defects... Show more

HRGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HRGN with price predictions
Jun 27, 2025

Momentum Indicator for HRGN turns negative, indicating new downward trend

HRGN saw its Momentum Indicator move below the 0 level on June 17, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 125 similar instances where the indicator turned negative. In of the 125 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 56 cases where HRGN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

HRGN moved below its 50-day moving average on June 09, 2025 date and that indicates a change from an upward trend to a downward trend.

The Aroon Indicator for HRGN entered a downward trend on June 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HRGN's RSI Oscillator exited the oversold zone, of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for HRGN just turned positive on June 26, 2025. Looking at past instances where HRGN's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

HRGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.438) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). HRGN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (58.480) is also within normal values, averaging (252.247).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. HRGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HRGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
HRGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
84 October Hill Road
Phone
+1 774 233-7300
Employees
18
Web
https://www.biostage.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TTDKY11.740.64
+5.78%
TDK Corp.
INIS0.07N/A
+3.02%
International Isotopes, Inc.
FUJSF18.70N/A
N/A
Fuji Seal, Inc.
NGKSY17.24N/A
N/A
NITERRA CO LTD.
WHLT0.08N/A
N/A
Chase Packaging Corp.

HRGN and Stocks

Correlation & Price change

A.I.dvisor tells us that HRGN and CADL have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HRGN and CADL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRGN
1D Price
Change %
HRGN100%
N/A
CADL - HRGN
27%
Poorly correlated
N/A
GENFF - HRGN
6%
Poorly correlated
N/A
APLM - HRGN
6%
Poorly correlated
+1.51%
APGE - HRGN
4%
Poorly correlated
N/A
SXTP - HRGN
2%
Poorly correlated
-5.74%
More